Latest Patents News

Jindalee Lithium is progressing its McDermitt Lithium Project with a proposed US SPAC listing, government backing, and an $8 million capital raise, positioning it as a key player in the US critical minerals landscape.

Cann Group Limited has secured a short-term extension on its National Australia Bank debt facilities and is finalising a $15.3 million settlement deed to release all associated securities.

Titomic Limited has launched a major European manufacturing hub and a UK subsidiary, secured a $50 million capital raise, and forged strategic partnerships to advance its cold spray additive manufacturing technology.

Thor Energy reported a transformative quarter with standout natural hydrogen and helium exploration results at its HY-Range Project, alongside significant asset sales that strengthen its financial position.

Firebird Metals has advanced its manganese-rich battery materials strategy with new Chinese patents, a significant kiln sales interest, and a A$6 million capital raise, alongside key leadership changes.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Papyrus Australia has taken a major step towards commercialisation by signing a $4.2 million binding Terms Sheet with TBS Mining Solutions and progressing a high-volume production facility in Vietnam. The company also secured a $250,000 government grant and restructured its leadership to support growth.

First Graphene Limited has reported its strongest first quarter sales ever for its PureGRAPH products, alongside new product launches and strategic partnerships that position it at the forefront of advanced materials innovation.

Talga Group has made significant strides in Q1 FY2026 with key partnerships in the US and Germany, new patents, and a substantial Swedish government grant to advance its battery anode production.

Biotron Limited has advanced its Hepatitis B antiviral program while preparing to acquire Sedarex Limited, backed by a $2.5 million capital raise. The move signals a strategic expansion into safer anaesthetics alongside ongoing R&D progress.

Dotz Nano has secured its first commercial order for its advanced carbon capture sorbent and raised A$1.2 million to accelerate development of its DotzEarth technology, marking a pivotal step towards commercialization in the growing DAC market.

Identitii Limited has signed six new data sharing agreements with NSW clubs, expanded its BNDRY platform capabilities, and welcomed major shareholder Cameron Beavis to its board, signaling strong momentum ahead.